Health Catalyst Reports on Shareholder Vote Matters

TL;DR

Health Catalyst held a shareholder vote on June 13th, details filed today.

AI Summary

Health Catalyst, Inc. filed an 8-K on June 17, 2024, reporting on matters submitted to a vote of security holders on June 13, 2024. The filing details the company's corporate actions and decisions put before its shareholders.

Why It Matters

This filing informs investors about key decisions made by Health Catalyst, Inc. that were voted on by shareholders, impacting corporate governance and future direction.

Risk Assessment

Risk Level: low — This is a routine filing reporting on a shareholder vote, not indicating new financial distress or significant operational changes.

Key Players & Entities

• Health Catalyst, Inc. (company) — Registrant
• June 13, 2024 (date) — Date of earliest event reported
• June 17, 2024 (date) — Date of report
• Delaware (jurisdiction) — State of incorporation
• 10897 South River Front Parkway #300 (address) — Principal executive office address
• South Jordan, UT 84095 (address) — Principal executive office location

FAQ

Key Financial Figures

• $0.001 — ich registered Common Stock, par value $0.001 per share HCAT The Nasdaq Global Select

Filing Documents

• hcat-20240613.htm (8-K) — 35KB
• 0001636422-24-000097.txt ( ) — 195KB
• hcat-20240613.xsd (EX-101.SCH) — 2KB
• hcat-20240613_def.xml (EX-101.DEF) — 15KB
• hcat-20240613_lab.xml (EX-101.LAB) — 27KB
• hcat-20240613_pre.xml (EX-101.PRE) — 16KB
• hcat-20240613_htm.xml (XML) — 3KB

07. Submission of Matters to a Vote of Security Holders

Item 5.07. Submission of Matters to a Vote of Security Holders. On June 13, 2024, Health Catalyst, Inc. (the "Company") held its annual meeting of stockholders (the "Annual Meeting"). The Company's stockholders voted on three proposals at the Annual Meeting, each of which is described in greater detail in the Company's definitive proxy statement filed with the U.S. Securities and Exchange Commission on April 29, 2024. The number of shares of the Company's common stock entitled to vote at the Annual Meeting was 59,033,536. The number of shares of the Company's common stock present or represented by valid proxy at the Annual Meeting was 49,177,309. The final voting results with respect to each such proposal are set forth below. Proposal 1 – Election of Directors The Company's stockholders elected each of the three persons named below to serve as a Class II director of the Company to serve a three-year term expiring at the 2027 annual meeting of the stockholders or until their successors are duly elected and qualified, subject to their earlier removal or resignation. The results of such vote were as follows: Director Name Votes For Votes Withheld Broker Non-Votes Daniel Burton 31,119,449 12,090,333 5,967,527 John A. Kane 30,312,852 12,896,930 5,967,527 Julie Larson-Green 30,723,384 12,486,398 5,967,527 Proposal 2 – Ratification of the Appointment of the Company's Independent Registered Public Accounting Firm The Company's stockholders ratified the appointment of Ernst & Young LLP to perform the audit of the Company's consolidated financial statements for the fiscal year ending December 31, 2024. The results of such vote were as follows: Votes For Votes Against Abstentions 49,068,137 106,662 2,510 Proposal 3 – Advisory, Non-Binding Vote to Approve the Compensation of the Company's Named Executive Officers The stockholders approved the advisory, non-binding proposal to approve the compensation of the Company's named executive officers. The results o

View Full Filing

View this 8-K filing on SEC EDGAR